TIL
Instil Bio Inc.
NASDAQ: TIL · HEALTHCARE · BIOTECHNOLOGY
$7.85
-2.85% today
Updated 2026-04-29
Market cap
$54.80M
P/E ratio
—
P/S ratio
54,248.82x
EPS (TTM)
$-10.70
Dividend yield
—
52W range
$6 – $43
Volume
0.0M
Instil Bio Inc. (TIL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-50.40%
ROA
-14.20%
Debt/equity
0.71x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-6.45M | — | — | — |
| 2020 | $138000.00 | $-37.74M | 100.00% | -24,379.71% | -27,346.38% |
| 2021 | $0.00 | $-156.79M | — | — | — |
| 2022 | $0.00 | $-223.18M | — | — | — |
| 2023 | $0.00 | $-156.09M | — | — | — |
| 2024 | $0.00 | $-74.14M | — | — | — |
| 2025 | $0.00 | $-71.37M | — | — | — |